/CU6

CU6

Updated 10 July 08:16 am

$2.41

CLARITY PHARMACEUTICALS LTD

1D+1.69%
1M+14.69%
1Y-14.49%
Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Track your position in CU6

Sign in to TradeLedgr to record trades in CU6 (CLARITY PHARMACEUTICALS LTD) with parcel-level precision and ATO-compliant reporting.

Recent Announcements

07 Jul 2026 10:23 PM
629KB
Ceasing to be a substantial holder
Ceasing to be a substantial holder
06 Jul 2026 10:18 PM
302KB
Ceasing to be a substantial holder
Ceasing to be a substantial holder
01 Jul 2026 7:11 AM
233KB
Cleansing Notice
Cleansing Notice
Appendix 2A
30 Jun 2026 10:18 PM
918KB
Becoming a substantial holder
Becoming a substantial holder

Fundamentals

P/E Ratio

-99999.99x

Div Yield

0.00%

EPS

$-0.2794

Avg Vol

2.3M

52W High

$5.870

52W Low

$1.970

Company Profile

Clarity is a clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology.

Corporate Website

Financial History

2025A

$-64.3M profit

$0.0M rev

2024A

$-42.3M profit

$0.0M rev

2023A

$-24.6M profit

$0.0M rev

CU6 | CLARITY PHARMACEUTICALS LTD — ASX Stock Data | TradeLedgr